Vergoeding 2016-2020 voor ATC-subgroep A10BH : Dipeptidylpeptidase-4-remmers
- Raming voor de totale Zvw-populatie
| 2016 | 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|---|
| A10BH01 Sitagliptine (Januvia ®) | 7.859.000 | 7.499.100 | 8.040.900 | 9.638.100 | 10.227.200 |
| A10BH02 Vildagliptine (Galvus ®) | 1.721.100 | 1.598.900 | 1.473.800 | 1.455.700 | 1.409.700 |
| A10BH03 Saxagliptine (Onglyza ®) | 580.850 | 484.410 | 416.150 | 390.760 | 345.380 |
| A10BH05 Linagliptine (Trajenta ®) | 2.308.800 | 2.364.300 | 2.478.900 | 2.904.000 | 3.244.800 |
| Totaal | 12.469.750 | 11.946.710 | 12.409.750 | 14.388.560 | 15.227.080 |